Markert
Bruce D. Markert, Jacksonville, FL US
Patent application number | Description | Published |
---|---|---|
20130168129 | MOUNTING DEVICE AND METHOD OF ASSEMBLING THE SAME - A method of assembling a mounting device for an electrical harness of a gas turbine engine is provided. The electrical harness has a wire bundle. The method includes providing a first shell and providing a second shell. The method further includes coupling the first shell to the second shell with the wire bundle disposed between the first shell and the second shell such that movement of the first shell and the second shell along the wire bundle is restricted. | 07-04-2013 |
20140318861 | MOUNTING DEVICE AND METHOD OF ASSEMBLING THE SAME - A method and system for a mounting device for an electrical harness of a gas turbine engine are provided. The mounting device includes a first and a second semi-cylindrical shell, the first and second shells are hingedly coupled along respective adjacent edges. Each of the first and second shells includes a first end region, a second end region and a middle region extending between the first end region and the second end region. The middle region defines a mounting seat having an outer diameter that is less than an outer diameter of the first end region and the second end region. The mounting device also includes at least one fastener configured to couple the first shell to the second shell with the wire bundle disposed between the first shell and the second shell such that movement of the first shell and the second shell along the wire bundle is restricted. | 10-30-2014 |
Carol Theresa Markert, Brighton, CO US
Patent application number | Description | Published |
---|---|---|
20130257613 | MOBILE DURESS DYNAMIC REGISTRATION AND PENDANT MANAGEMENT SYSTEM - A system for transmitting information in a wireless network includes at least one mobile transponder, each transponder adapted to be on the person of a user; an area controller gateway for controlling and managing the network, the area controller gateway operatively connected to the at least one mobile transponder; and a central monitoring station adapted to receive information from the at least one mobile transponder via the area controller gateway and to transmit other information to the at least one mobile transponder via the area controller gateway. The central monitoring station is operatively connected to the area controller gateway by an interne or cellular connection. The system may include a repeater adapted to receive information from the at least one mobile transponder and to transmit said information to the area controller gateway. The mobile transponder may be a duress pendant to provide duress notification or coverage to the user. | 10-03-2013 |
Charles D. Markert, Purcellville, VA US
Patent application number | Description | Published |
---|---|---|
20130215706 | METHOD AND APPARATUS FOR CREATING CAVITATION FOR BLENDING AND EMULSIFYING - The present invention relates to a device for emulsifying a mixture. The device includes a body defining a cavitation chamber, the body comprising a first and second opening and the cavitation chamber comprising an entry port and an exit port. The first opening is connected to the entry port and the second opening is connected to the exit port. The device includes a replaceable nozzle positioned in the entry port and an adjustable counter baffle positioned in the cavitation chamber to impinge flow of solution entering the cavitation chamber from the nozzle. Also disclosed is a method of emulsifying a mixture. This method involves providing the device of the present invention, introducing a mixture into the first opening of the device, and recovering an emulsified solution from the second opening of the device. | 08-22-2013 |
20140041288 | REAL TIME IN-LINE WATER-IN-FUEL EMULSION APPARATUS, PROCESS AND SYSTEM - A water-in-fuel emulsion system comprises a reactor device, a fuel intake connected to said reactor device, a water intake connected to said reactor device, a pump connected to said reactor device, and a circulating emulsion reprocessing inline loop connected to said pump and feeding a load as needed in real time, wherein said reactor device comprises a non-vibrating anvil shaped to create cavitation sufficient to emulsify water-in-fuel from said water intake and said fuel intake. | 02-13-2014 |
20140345722 | EMULSION-PRODUCING HYDRAULIC CIRCUIT AND METHOD FOR RE-EMULSIFYING A SEPARATED LIQUID - The present invention relates to an emulsion-producing hydraulic circuit. The hydraulic circuit includes a by-pass loop comprising a first end and a second end, where the first end of the by-pass loop and the second end of the by-pass loop are connected to a supply line of the hydraulic circuit before and after a pump. The asynchronous by-pass loop also includes a control valve, and the by-pass loop transfers a portion of an emulsion and/or any separated liquid that has accumulated in the hydraulic circuit to the supply line to be re-emulsified. Also disclosed is a method for re-emulsifying a separated liquid present in a hydraulic circuit. | 11-27-2014 |
Christian Markert, Riehen CH
Patent application number | Description | Published |
---|---|---|
20140350034 | Aminopyridine derivatives as plasma kallikrein inhibitors - The invention relates to compound of the formula (I) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it. | 11-27-2014 |
20140378474 | 5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors - The invention relates to a compound of the formula (I) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it. | 12-25-2014 |
Christian Markert, Basel CH
Patent application number | Description | Published |
---|---|---|
20120035168 | N-((6-AMINO-PYRIDIN-3-YL)METHYL)-HETEROARYL-CARBOXAMIDES - The invention relates to compound of the formula I | 02-09-2012 |
Dennis Markert, Maple Valley, WA US
Patent application number | Description | Published |
---|---|---|
20080309297 | USB CHARGER FOR COMMERCIAL TRANSPORT VEHICLE - An outlet provides both AC and DC power to at least one device. The outlet includes an input portion adapted to receive a first voltage input and a second voltage input wherein the first voltage input is a variable DC voltage and the second input is AC of a desired voltage and frequency. A converter reduces the first input voltage to a constant DC voltage output effective to power a PED. The outlet has a first receptacle in the form of a USB port to deliver the DC power to the device and a second receptacle to deliver the AC power to the device. A sensing circuit is coupled to the outlet and determines if a source of the second voltage may safely provide the AC power. An enabling mechanism individually activates the second receptacle dependent on the determination of the sensing circuit and first and second indicators identify to a user if the first receptacle and/or the second receptacle is activated | 12-18-2008 |
James Markert, Birmingham, AL US
Patent application number | Description | Published |
---|---|---|
20080206199 | Chimeric Herpes Viruses and Uses Thereof - Disclosed herein are chimeric herpesviruses as well as methods of making and using such chimeric herpesviruses. The chimeric viruses comprise two nucleic acid sequences, one from a herpesvirus and one from a different virus. The herpesvirus nucleic acid sequence is a modified protein kinase R (PKR) evasion gene. The second viral nucleic acid sequence inhibits PKR-mediate protein shutoff in tumor cells, but is not neurovirulent. Thus, the chimeric virus has reduced neurovirulence as compared to the wild-type herpesvirus but remains replication competent. | 08-28-2008 |
James Macdowell Markert, Birmingham, AL US
Patent application number | Description | Published |
---|---|---|
20090186003 | HERPES SIMPLEX VIRUS EXPRESSING FOREIGN GENES AND METHOD FOR TREATING CANCERS THEREWITH - An anti-cancer pharmaceutical composition includes a herpes simplex virus (HSV) vector into which a nucleic acid sequence encoding for an anti-cancer agent selected from interleukin-12, GM-CSF, and CD has been inserted. A method of treatment of a patient suffering from cancer includes administering to the patient the anti-tumor pharmaceutical composition including a HSV vector having a nucleic acid sequence encoding for an anti-cancer agent selected from interleukin-12, GM-CSF, and CD inserted therein. | 07-23-2009 |
Lotte Markert, Arhus V DK
Patent application number | Description | Published |
---|---|---|
20080208351 | Biocompatible Material for Surgical Implants and Cell Guiding Tissue Culture Surfaces - A biocompatible material, wherein at least a part of a surface of the biocompatible material is characterized by a micro or nano-meter scale topographical structure comprising a plurality of features where the structure is selected to promote a predetermined cell function in vivo or ex vivo in cell or tissue culture. | 08-28-2008 |
Lotte Markert, Arhus DK
Patent application number | Description | Published |
---|---|---|
20110160869 | BIOCOMPATIBLE MATERIALS FOR MAMMALIAN STEM CELL GROWTH AND DIFFERENTIATION - A biocompatible material, wherein at least a part of a surface of the biocompatible material is characterized by a micro or nano-meter scale topographical structure comprising a plurality of features where the structure is selected to promote the growth of undifferentiated pluripotent stem cells or serve to promote the uniform differentiated growth of stem cells. Furthermore, a biocompatible material is provided having a surface structure and composition that affects a cellular function, in particular cellular functions related to gene induction, cell differentiation and the formation of bone tissue in vivo and ex-vivo. | 06-30-2011 |
Matthew C. Markert, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20130317591 | DRUG ELUTING STENT FOR THE TREATMENT OF DIALYSIS GRAFT STENOSES - A drug-eluting stent having a first cell pattern at one end and a second cell pattern on an opposite end. The cells in the first cell pattern have a smaller MCUSA than those in the second cell pattern. An anti-restonic drug can be coated on the first cell pattern and an anti-thrombotic drug on the second, with the anti-thrombotic drug overlaying and covering both the first and second cell patterns. The stent is operatively positionable at a distal graft-vein anastomosis with the first cell pattern adjacent the stenosis, and with the second cell pattern positioned adjacent the vein or the graft. | 11-28-2013 |
Michael Markert, Fort Lauderdale, FL US
Patent application number | Description | Published |
---|---|---|
20120134474 | HANDSWITCH QUICK CONNECT EXPOSURE CONTROL - A radiation imaging system includes a radiation detector for detecting radiation emitted from a radiation generator; a quick-connect unit configured to activate the radiation generator to initiate radiation emission and to activate the radiation detector to initiate detection of the radiation; and a notification unit included within the quick-connect unit that is configured to notify an operator of a time when the radiation detector is ready to detect the radiation. The quick-connect unit is connectable to the radiation detector and the radiation generator without having to make hardware modifications therein. In an alternate embodiment, the quick-connect unit is a handswitch to be held by an operator, where the notification unit notifies the operator that the radiation detector is ready to detect the radiation, by emitting at least one of a visual signal, a tactile signal and an audible signal. | 05-31-2012 |
M. Louise Markert, Durham,, NC US
Patent application number | Description | Published |
---|---|---|
20090041854 | PARATHYROID AND THYMUS TRANSPLANTATION IN DIGEORGE SYNDROME SUBJECTS - A method of treating hypoparathyroidism in a human DiGeorge syndrome subject comprises (a) implanting thymus tissue into the subject in an amount effective to treat the DiGeorge syndrome; and (b) implanting, preferably concurrently implanting, parathyroid tissue into the subject in an amount effective to treat the hypoparathyroidism. | 02-12-2009 |